Enanta Pharmaceuticals Statistics
NASDAQ: ENTAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.62-0.36 (-4.51%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Enanta Pharmaceuticals by the numbers
Enanta Pharmaceuticals has a market capitalization of $222.2 million based on 29.16M shares outstanding. With trailing EPS of $-2.35, Enanta Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 33.6% below its 50-day average and 41.3% below its 200-day average.
Average daily trading volume is 287.81K shares, or about $2.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ENTA valuation vs. peer median
| Metric | ENTA | Peer median | Difference |
|---|---|---|---|
| Market cap | $222.19M | $216.96M | +2% |
| Avg. volume | 287.81K | 954.92K | -70% |
Peer median across 8 companies: IMRX, RCKT, KROS, PYXS, ARCT, CYPH, VNDA, CAMP.
Valuation
- Market cap
- $222.19M
- Price / sales (latest FY)
- 3.53
- EPS (TTM)
- $-2.35
- Shares outstanding
- 29.16M
Price and trading
- Previous close
- 7.98
- Open
- 7.82
- Day range
- 7.56 – 8.06
- 52-week range
- 7.56 – 17.15
- 52-week change
- -40.14%
- Beta
- —
- Volume
- 457.63K
- Average volume
- 287.81K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 16, 2026
Additional statistics
- Market Cap
- 222.19M
- Forward Pe
- -3.56
- Eps
- -2.35
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 17.15
- Week52 Low
- 7.56
- Avg Volume
- 287.81K
- Shares Outstanding
- 29.16M
- Ma50
- 11.48
- Ma200
- 12.98
- Earnings Date
- Nov 16, 2026
- Pct From52w High
- -55.57%
- Pct From52w Low
- 0.79%